immunocompromised /tags/immunocompromised immunocompromised en-US WLRN Fri, 18 Mar 2022 13:14:18 GMT Lifesaving COVID drugs are sitting unused on pharmacy shelves, HHS data shows /2022-03-18/lifesaving-covid-drugs-are-sitting-unused-on-pharmacy-shelves-hhs-data-shows States and health providers report they've dispensed less than half their supply from the government, raising fears that the drugs may go to waste while people who could benefit get sicker. Fri, 18 Mar 2022 13:14:18 GMT /2022-03-18/lifesaving-covid-drugs-are-sitting-unused-on-pharmacy-shelves-hhs-data-shows Pien Huang The White House says it's running out of money to cover COVID tests and vaccines /news/national-politics/2022-03-15/the-white-house-says-its-running-out-of-money-to-cover-covid-tests-and-vaccines The White House asked for more money from Congress to keep its COVID response going. But that hasn't happened, so some things need to be wound down. Tue, 15 Mar 2022 16:56:23 GMT /news/national-politics/2022-03-15/the-white-house-says-its-running-out-of-money-to-cover-covid-tests-and-vaccines Tamara Keith, Kelsey Snell The White House has a new plan for COVID-19 aimed at getting things back to normal /2022-03-02/the-white-house-has-a-new-plan-for-covid-19-aimed-at-getting-things-back-to-normal If you think you might have COVID-19 and are at high risk, you may be able to get tested at a clinic and treated with antiviral drugs right away, under the next phase of the pandemic plan. Wed, 02 Mar 2022 17:15:19 GMT /2022-03-02/the-white-house-has-a-new-plan-for-covid-19-aimed-at-getting-things-back-to-normal Tamara Keith Evusheld offers another layer of protection for patients who may not respond well to COVID-19 vaccines /news/2022-02-01/evusheld-offers-another-layer-of-protection-for-patients-who-may-not-respond-well-to-covid-19-vaccines Unlike other monoclonal antibody therapies, Evusheld is not meant to treat active coronavirus infection. Instead, it's preventative medicine for people with compromised immune systems. Tue, 01 Feb 2022 14:09:10 GMT /news/2022-02-01/evusheld-offers-another-layer-of-protection-for-patients-who-may-not-respond-well-to-covid-19-vaccines Stephanie Colombini There's one population that gets overlooked by an 'everyone will get COVID' mentality /news/npr-breaking-news/2022-01-26/theres-one-population-that-gets-overlooked-by-an-everyone-will-get-covid-mentality The roughly 7 million Americans who are immunocompromised — including many people with disabilities — live with much higher risk of COVID-19, and near-constant vigilance. Wed, 26 Jan 2022 15:00:00 GMT /news/npr-breaking-news/2022-01-26/theres-one-population-that-gets-overlooked-by-an-everyone-will-get-covid-mentality Lesley McClurg Hospitals use a lottery to allocate scarce COVID drugs for the immunocompromised /2022-01-25/hospitals-use-a-lottery-to-allocate-scarce-covid-drugs-for-the-immunocompromised So far the government has distributed nearly 400,000 doses of Evusheld, a new drug that protects against COVID-19. Some 7 million Americans could benefit from the drug right away. Wed, 26 Jan 2022 11:08:34 GMT /2022-01-25/hospitals-use-a-lottery-to-allocate-scarce-covid-drugs-for-the-immunocompromised Pien Huang